Remdesivir: a pendulum in a pandemic.

Schwartz, Ilan S; Heil, Emily L; McCreary, Erin K

Schwartz, Ilan S; Heil, Emily L; McCreary, Erin K.

Schwartz IS; Division of Infectious Diseases, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.
Heil EL; Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
McCreary EK; Department of Medicine, Division of Infectious Diseases, UPMC Health System and the University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA mccrearye3@upmc.edu.

BMJ ; 371: m4560, 2020 11 24.

Article in English | MEDLINE | ID: covidwho-944918

Subject(s)

Adenosine Monophosphate/analogs & derivatives; Alanine/analogs & derivatives; Antiviral Agents/therapeutic use; COVID-19 Drug Treatment; SARS-CoV-2/drug effects; Adenosine Monophosphate/therapeutic use; Alanine/therapeutic use; Humans; Randomized Controlled Trials as Topic; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Adenosine Monophosphate / Alanine / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: BMJ Journal subject: Medicine Year: 2020 Document Type: Article Affiliation country: Bmj.m4560

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google